Search

Your search keyword '"Ling Ping Lai"' showing total 316 results

Search Constraints

Start Over You searched for: Author "Ling Ping Lai" Remove constraint Author: "Ling Ping Lai"
316 results on '"Ling Ping Lai"'

Search Results

1. Sex-based differences in obstructive sleep apnea and atrial fibrillation: Implication of atrial fibrillation burden

2. Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism

3. Unique clinical features and long term follow up of survivors of sudden cardiac death in an Asian multicenter study

4. Medical students’ affective reactions to workplace experiences: qualitative investigation in a Chinese cultural context

5. Correlation Between CHA2DS2-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study

7. GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death

8. Atrial flutter/fibrillation in patients receiving transcatheter closure of atrial septal defect

9. Renal Denervation Decreases Susceptibility to Arrhythmogenic Cardiac Alternans and Ventricular Arrhythmia in a Rat Model of Post-Myocardial Infarction Heart Failure

10. Impact of Ancestral Differences and Reassessment of the Classification of Previously Reported Pathogenic Variants in Patients With Brugada Syndrome in the Genomic Era: A SADS-TW BrS Registry

11. Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation

12. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan

13. Unique clinical features and long term follow up of survivors of sudden cardiac death in an Asian multicenter study

14. An observational study: The utility of perfusion index as a discharge criterion for pain assessment in the postanesthesia care unit.

15. Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis.

16. Next-generation sequencing and bioinformatics to identify genetic causes of malignant hyperthermia

18. Brugada-Type Electrocardiogram in the Taiwanese Population–Is it a Risk Factor for Sudden Death?

19. The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders

20. The Potentially Protective Effects of Anti-Lipid, Hypoglycemic, and Anti-Hypertensive Agents for Perioperative Mortality in Geriatric Group

21. Arrhythmogenic Right Ventricular Dysplasia: Clinical Characteristics and Identification of Novel Desmosome Gene Mutations

22. Predictors of Therapeutic Response to Beta-blockers in Patients with Heart Failure in Taiwan

23. Amiodarone-related Pneumonitis

24. Human C-reactive Protein (CRP) Gene 1059 G > C Polymorphism is Associated with Plasma CRP Concentration in Patients Receiving Coronary Angiography

25. Repolarization Alternans and Ventricular Arrhythmia in a Repaired Tetralogy of Fallot Animal Model

26. Paralysis Periodica Paramyotonica Caused by SCN4A Arg1448Cys Mutation

27. A new method to derive fetal heart rate from maternal abdominal electrocardiogram: monitoring fetal heart rate during cesarean section.

28. The effect and molecular mechanism of statins on the expression of human anti-coagulation genes

29. Poorer Exercise Accommodation of Regional Systolic Myocardial Motion after Spironolactone Treatment in Heart Failure Patients with Preserved Ejection Fraction and Ventricular Dyssynchrony

30. Investigate clinical characteristics and genetic mutations of CPVT patients in Taiwan and risk stratification

31. Perfusion index derived from a pulse oximeter can detect changes in peripheral microcirculation during uretero-renal-scopy stone manipulation (URS-SM).

33. Long-term outcomes and left ventricular diastolic function of sarcomere mutation-positive and mutation-negative patients with hypertrophic cardiomyopathy: a prospective cohort study

34. Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome

35. GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death

36. C‐reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10‐year prospective follow‐up study

37. Erratum to: Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms

38. P1604Validating previously reported Brugada syndrome-associated common variants identified in caucasian population in the Han Chinese BrS cohort in Taiwan: SADS-BrS registry

39. P5269The impact of sarcomeric mutations on myocardial fibrosis and ventricular diastolic function in hypertrophic cardiomyopathy (SADS-TW HCM registry study)

40. P5699Functional studies of a novel copy number deletion in GSTM3 gene associated with increase of ventricular arrhythmia in patients with Brugada syndrome and ICD implantation

42. Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation

43. Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy

44. Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease

45. Prevalence and prognosis of Brugada electrocardiogram patterns in an elderly Han Chinese population: a nation-wide community-based study (HALST cohort)

46. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan

47. TNF- down-regulates sarcoplasmic reticulum Ca2+ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF- B to promoter response element

48. Acute Effects of Biventricular Pacing in Heart Failure Patients with a Normal Ejection Fraction and Mechanical Dyssynchrony

49. Comparisons of clinical impacts on individuals with Brugada electrocardiographic patterns defined by ISHNE criteria or EHRA/HRS/APHRS criteria: a nationwide community-based study

50. Additive effect of the metabolic syndrome score to the conventional CHADS2 score for the thromboembolic risk stratification of patients with atrial fibrillation

Catalog

Books, media, physical & digital resources